[Pathological evaluation of advanced gastric cancer after neoadjuvant chemotherapy].
APA
Xing J, Yang LY, et al. (2025). [Pathological evaluation of advanced gastric cancer after neoadjuvant chemotherapy].. Zhonghua bing li xue za zhi = Chinese journal of pathology, 54(2), 210-214. https://doi.org/10.3760/cma.j.cn112151-20240911-00608
MLA
Xing J, et al.. "[Pathological evaluation of advanced gastric cancer after neoadjuvant chemotherapy].." Zhonghua bing li xue za zhi = Chinese journal of pathology, vol. 54, no. 2, 2025, pp. 210-214.
PMID
39863545
MeSH Terms
Humans; Stomach Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Chemotherapy, Adjuvant; Antineoplastic Combined Chemotherapy Protocols; Lymphatic Metastasis; Lymph Nodes; Gastrectomy
같은 제1저자의 인용 많은 논문 (3)
- Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes.
- Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy.
- Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests.